Cutia Therapeutics (HKG:2487)
Hong Kong · Delayed Price · Currency is HKD 4.700
+0.330 (7.55%)
At close: Mar 6, 2026
Cutia Therapeutics Market Cap
Cutia Therapeutics has a market cap or net worth of 1.71 billion as of March 6, 2026. Its market cap has decreased by -3.41% in one year.
Market Cap
1.71B
Enterprise Value
1.28B
Revenue
274.31M
Ranking
n/a
PE Ratio
n/a
Stock Price
4.70
Market Cap Chart
Since June 12, 2023, Cutia Therapeutics's market cap has decreased from 6.67B to 1.71B, a decrease of -74.41%. That is a compound annual growth rate of -39.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 1.71B | 3.52% |
| Dec 31, 2025 | 1.65B | -26.86% |
| Dec 31, 2024 | 2.26B | -32.43% |
| Dec 29, 2023 | 3.34B | -49.98% |
| Jun 12, 2023 | 6.67B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Clover Biopharmaceuticals | 2.31B |
| Frontage Holdings | 2.19B |
| Antengene Corporation | 2.15B |
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 2.04B |
| Zhaoke Ophthalmology | 1.74B |
| Mabpharm | 1.65B |
| ImmuneOnco Biopharmaceuticals (Shanghai) | 1.53B |
| Immunotech Biopharm | 1.45B |